A study of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft tissue sarcoma.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sant P. Chawla, Patrick Schoffski, Jean-Yves Blay, Robin Lewis Jones, Hans Gelderblom, Steven Attia, Bartosz Chmielowski, Brian Andrew Van Tine, Jonathan C. Trent, Shreyaskumar Patel, Andrew J. Wagner, James Kert Viele, Rashmi Chugh, Axel Le Cesne, Gabriel Tinoco, Kamalesh Kumar Sankhala, Julianne Falcone, Charles Schweizer, Susan Weil, Robert G. Maki
Institutions: Sarcoma Oncology Center, Universitair Ziekenhuis Leuven, Centre Léon Bérard, Royal Marsden Hospital, Leiden University Medical Center, Mayo Clinic in Florida, University of California, Los Angeles, Washington University in St. Louis, University of Miami, Sylvester Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Berry Consultants, LLC (United States), University of Michigan, Michigan Medicine, Institut Gustave Roussy, Jackson Memorial Hospital, Morphotek (United States), Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598317535